Horizon to acquire biotechnology firm Viela Bio for $3bn
Ireland-based biopharmaceutical firm Horizon Therapeutics has reached an agreement to acquire Maryland-based biotechnology firm Viela Bio. Under the terms of the merger agreement, Horizon will acquire all of